藍帆醫療(002382.SZ):收購武漢必凱爾100%股權、CBCH II 6.63%股權交割完成
格隆匯 7 月 24日丨藍帆醫療(002382.SZ)公佈,公司已按照《股權轉讓協議》的約定向業績承諾主體隋建勛、樊芙蓉全額支付了第一期股權轉讓款合計4064.06萬元,向珠海藍帆巨擎股權投資中心(有限合夥)全額支付了股權轉讓款14586萬元,目前各方已按照《股權轉讓協議》的相關約定進行了交易交割,武漢必凱爾已經完成了工商登記手續並,取得了變更後的《營業執照》。公司已經成為直接持有武漢必凱爾100%股權的股東,依法享有法律和公司章程規定的各項股東權利並承擔相應股東義務;武漢必凱爾已成為公司的全資子公司,並將納入公司合併報表範圍。
公司已按照《股權轉讓協議》的約定向CBCH II的股東CPBL Limited全額支付了交易價款6353.17萬美元。截至2020年7月23日,公司已收到CPBL Limited就確認《股權轉讓協議》項下全部合同義務已全面、充分和適當地履行而出具的《確認函》,並取得了CBCH II更新後的《股東名冊(RegisterofMembers)》。藍帆醫療已經成為直接及間接持有CBCH II 100%股權的股東,依法享有法律和公司章程規定的各項股東權利並承擔相應股東義務,CBCH II已成為公司的全資子公司。
目前,公司正在辦理CBCH II的工商登記變更及其他相關事項,並將根據事件的後續進展情況,按照法律法規的要求,及時履行信息披露義務,提請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.